In various tumor types, continuous NF-κB signaling pathway activation in CAFs facilitates tumor progression and triggers inhibitory immune cell infiltration by secreting IL6, IL8, and other inflammatory molecules (33, 50). This evidence concerns the gene NFKB1 and neoplasm.